APA

Molino A., Guglielmo L., Azzolini M. E., Biondani P., Capelli M. C., Grandinetti A., Griso C., Martinelli G., Martini N. & Zanotti R. (19910401). The antiemetic activity of high-dose metoclopramide and high-dose alizapride in combination with lorazepam in patients receiving cancer chemotherapy. A prospective, randomized, double-blind study. : Oncology.

Chicago

Molino A, Guglielmo L, Azzolini M E, Biondani P, Capelli M C, Grandinetti A, Griso C, Martinelli G, Martini N and Zanotti R. 19910401. The antiemetic activity of high-dose metoclopramide and high-dose alizapride in combination with lorazepam in patients receiving cancer chemotherapy. A prospective, randomized, double-blind study. : Oncology.

Harvard

Molino A., Guglielmo L., Azzolini M. E., Biondani P., Capelli M. C., Grandinetti A., Griso C., Martinelli G., Martini N. and Zanotti R. (19910401). The antiemetic activity of high-dose metoclopramide and high-dose alizapride in combination with lorazepam in patients receiving cancer chemotherapy. A prospective, randomized, double-blind study. : Oncology.

MLA

Molino A, Guglielmo L, Azzolini M E, Biondani P, Capelli M C, Grandinetti A, Griso C, Martinelli G, Martini N and Zanotti R. The antiemetic activity of high-dose metoclopramide and high-dose alizapride in combination with lorazepam in patients receiving cancer chemotherapy. A prospective, randomized, double-blind study. : Oncology. 19910401.